ProQR In-licenses Worldwide Rights to Ophthalmology Drug Candidate from Ionis Pharmaceuticals Life Science Investing
United States Department of Health and Human Services Publishes New HIV Treatment Guidelines Including Trogarzo Life Science Investing
Athenex Announces FDA Allowance of Investigational New Drug Application of Eribulin ORA to Begin Clinical Trials Pharmaceutical Investing
VistaGen Therapeutics Acquires Worldwide Rights to Develop and Commercialize PH10 Pharmaceutical Investing
Ovid Therapeutics Presents Additional Data and Analyses from the Phase 2 STARS Clinical Trial with OV101 Pharmaceutical Investing
Forward Pharma Provides Update on the Decision of the Federal Circuit in its Appeal of the U.S. Patent Interference Life Science Investing
BeiGene Announces Acceptance of its New Drug Application in China and Top-Line Pivotal Data for Zanubrutinib Pharmaceutical Investing
